⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGM

XNCR

Xencor, Inc.

Healthcare · Biotechnology

29.33USD

+4.1500 (+16.49%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on XNCR.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 29.33
P/E—
Dvd Ind Yld0.0%
P/B4.31
P/S20.7
Curr EV/T12M EBITDA-9.1
Mkt Cap (USD)2.2B
Curr EV (USD)1.9B
2)

Per Share Data

EPS T12M-2.17
DPS—
Bk Val Per Sh6.77
Rev/Sh1.38
Cash/Sh6.14
Curr Shares Out74.4M
FCF/Sh-2.75
3)

Cash Flow Analysis

P/CF-10.5
Curr P/FCF-10.4
CF/NI1.3
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-196.1%
Eff Interest Rate21.7%
4)

Growth Potential

Dil EPS 1Y Gr65.4%
Cap 1Y Gr-10.2%
BPS 1Y Gr-17.8%
R&D To Sales243.6%
Retention Rate100.0%
Rev 1Y Gr13.7%
FCF 1Y Gr33.6%
Assets 1Y Gr-8.0%
5)

Profitability

EBITDA-0.2B
EBIT-0.2B
Operating Margin-205.8%
Pretax Margin-153.2%
Net Margin-155.6%
ROA-20.4%
ROE-29.1%
ROC—
Asset Turnover0.13
6)

Structure

Current Ratio6.39
Quick Ratio6.09
Debt/Assets14.5%
Debt/Com Eq20.8%
Net Debt/EBITDA-0.29
Tot Debt/Capital17.2%
Gross Margin-143.6%
EBIT/Int Exp-8.0

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.